1. Home
  2. EYPT vs SPFI Comparison

EYPT vs SPFI Comparison

Compare EYPT & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SPFI
  • Stock Information
  • Founded
  • EYPT 1987
  • SPFI 1941
  • Country
  • EYPT United States
  • SPFI United States
  • Employees
  • EYPT N/A
  • SPFI N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SPFI Major Banks
  • Sector
  • EYPT Industrials
  • SPFI Finance
  • Exchange
  • EYPT Nasdaq
  • SPFI Nasdaq
  • Market Cap
  • EYPT 741.0M
  • SPFI 662.8M
  • IPO Year
  • EYPT 2005
  • SPFI 2019
  • Fundamental
  • Price
  • EYPT $14.00
  • SPFI $37.85
  • Analyst Decision
  • EYPT Strong Buy
  • SPFI Buy
  • Analyst Count
  • EYPT 6
  • SPFI 3
  • Target Price
  • EYPT $25.83
  • SPFI $41.67
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • SPFI 50.5K
  • Earning Date
  • EYPT 11-06-2025
  • SPFI 10-21-2025
  • Dividend Yield
  • EYPT N/A
  • SPFI 1.57%
  • EPS Growth
  • EYPT N/A
  • SPFI 19.09
  • EPS
  • EYPT N/A
  • SPFI 3.20
  • Revenue
  • EYPT $51,898,000.00
  • SPFI $199,001,000.00
  • Revenue This Year
  • EYPT N/A
  • SPFI $13.41
  • Revenue Next Year
  • EYPT N/A
  • SPFI $6.10
  • P/E Ratio
  • EYPT N/A
  • SPFI $11.95
  • Revenue Growth
  • EYPT 2.99
  • SPFI 7.49
  • 52 Week Low
  • EYPT $3.91
  • SPFI $30.01
  • 52 Week High
  • EYPT $14.91
  • SPFI $42.38
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 58.99
  • SPFI 40.12
  • Support Level
  • EYPT $13.00
  • SPFI $37.65
  • Resistance Level
  • EYPT $14.04
  • SPFI $39.59
  • Average True Range (ATR)
  • EYPT 0.93
  • SPFI 1.04
  • MACD
  • EYPT -0.08
  • SPFI -0.14
  • Stochastic Oscillator
  • EYPT 62.87
  • SPFI 9.63

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.

Share on Social Networks: